Products with Inhibitors bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN6781 | Triptoquinone A |
| 1. Triptoquinone A has anti-inflammatory activity, it can significantly suppress smooth muscle relaxation and increase in cyclic GMP levels by nitric oxide (NO) in an L-arginine-induced relaxation experiment. 2. Triptoquinone A may be a useful candidate for the development of a drug as a potent inhibitor of iNOS gene over-expression. 3. Triptoquinone A prevents ndotoxin-or interleukin-1 beta-promoted induction of nitric oxide synthase in vascular smooth muscle, thus inhibiting development of L-arginine-induced vasorelaxation. | |
| BCN6783 | Triptocalline A |
| 1. Triptocalline A shows an inhibitory effect on rat lens aldose reductase. | |
| BCN6791 | Cytosporone B |
| Cytosporone B is a naturally occurring agonist for Nur77, it also is a Salmonella pathogenicity island 1 (SPI-1)-inhibitor, it may have potential in drug development against antibiotic-resistant Salmonella. Cytosporone B can elevate blood glucose levels in fasting C57 mice, an effect that is accompanied by induction of multiple genes involved in gluconeogenesis. Cytosporone B can inhibit transforming growth factor-b (TGF-β)-induced contraction of human corneal fibroblasts (HCFs), likely as a result of its attenuation of the up-regulation of α-SMA expression. | |
| BCN8086 | N-(3-Methoxybenzyl)palmitamide |
|
1. N-(3-Methoxybenzyl)palmitamide can counteract the toxicity produced by Aβ (25-35). 2. N-(3-methoxybenzyl)palmitamide is a promising inhibitor of fatty acid amide hydrolase (FAAH) and could potentially offer a good alternative for the treatment of pain, inflammation and CNS degenerative disorders. |
|
| BCN8184 | Pulsatilla camphor |
| 1. Pulsatilla saponin D exhibits anticancer activities in various cancer types, it Inhibits autophagic flux and synergistically enhances the anticancer activity of chemotherapeutic agents against HeLa cells. 2. Pulsatilla saponin D has strong haemolytic activity. | |
